• This article has been double-blind peer reviewed
Non-vitamin K antagonist oral anticoagulants offer an alternative to warfarin and heparins for treating atrial fibrillation and venous thromboembolism
Abstract Blann A (2015) Benefits of a new class of oral anticoagulant. Nursing Times; 111: 16, 15-17.
The disadvantages of warfarin and heparins have led to the development of a new class of drugs known as non-vitamin K antagonist oral anticoagulants. These new drugs are effective, safe and do not need to be monitored with blood tests.